Continuing PSA screening in older men is common practice but not recommended, highlighting the need for clearer guidance.

Rashes are a common side effect of some prostate cancer treatments. Rarely, they may be caused by cancer cells.

Many other conditions can mimic the symptoms of prostate cancer, both in its early or advanced stages. Here's what you need ...

Elevated circulating tumor DNA (ctDNA) fraction and tumor suppressor gene loss are associated with worse prognosis in patients with prostate cancer liver metastases (PCLM), accord ...

Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

The MHRA has approved the product for three clinical settings, including identifying how far high-risk prostate cancer has ...

Sherrie Wood and her husband, Kenneth, were newly married when he was diagnosed with prostate cancer in 2003. He experienced ...

Research reveals men skipping prostate cancer screenings are 45% more likely to die from the disease. Evidence from a large European study indicates P ...

A combo of Xtandi (enzalutamide) and Talzenna (talazoparib) does improve overall survival for men with advanced prostate cancer, compared with Xtandi alone.

Speaking in a TikTok video, Doctor Suraj Kukadia, altered his followers to the key symptoms of prostate cancer. According to Cancer Research UK statistics, this disease is the most common form of ...